Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in ...

New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...

Researchers at McMaster University have made a discovery ... is expected to influence how doctors test for, and treat patients with, unusual or recurrent blood clotting, with the potential to ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

FendX Technologies (CSE:FNDX) announced that its Repel Wrap film has performed well in its first real-world testing at one of ...

Researchers at McMaster University have made a groundbreaking ... is expected to influence how doctors test for, and treat patients with, unusual or recurrent blood clotting, with the potential ...